The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125281022 12528102 2 F 20160714 20160705 20160728 EXP ES-PFIZER INC-2016313346 PFIZER MARTIN, A.. NAB-PACLITAXEL PLUS GEMCITABINE AS FIRST-LINE PALLIATIVE CHEMOTHERAPY IN A PATIENT WITH METASTATIC PANCREATIC CANCER WITH EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS OF 2. ONCOLOGY LETTERS. 2016;12 (1):727-730 61.00 YR F Y 46.00000 KG 20160728 OT ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125281022 12528102 1 PS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 400 MG/M2, DAYS 1, 8 AND 15 78339 400 MG/M**2
125281022 12528102 2 SS NAB-PACLITAXEL PACLITAXEL 1 Intravenous (not otherwise specified) 50 MG/M2, DAYS 1, 8 AND 15 0 50 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125281022 12528102 1 Adenocarcinoma pancreas
125281022 12528102 2 Adenocarcinoma pancreas

Outcome of event

Event ID CASEID OUTC COD
125281022 12528102 OT
125281022 12528102 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125281022 12528102 Anaemia
125281022 12528102 Asthenia
125281022 12528102 Cholangitis acute
125281022 12528102 Diarrhoea
125281022 12528102 Hepatotoxicity
125281022 12528102 Lymphopenia
125281022 12528102 Oedema peripheral
125281022 12528102 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125281022 12528102 1 201311 0
125281022 12528102 2 201311 0